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Oxygen supplementation is known to improve exercise capacity in patients with chronic obstructive pulmonary 
disease (COPD). Although some COPD patients use oxygen after exercise to relieve dyspnea, the effect of oxygen 
during recovery from exercise is not clearly understood. Exercise duration and dyspnea recovery time were studied 
in 18 patients with stable COPD. Patients exercised at a constant submaximal work rate on a treadmill ergometer 
until they no longer wished to continue. Oxygen, room air and compressed air were randomly administered in three 
consecutive post-exercise recovery periods. Dyspnea was scored on a 100 mm visual analog scale at 30 s intervals 
until return to baseline. An additional 20 minute post-recovery resting period was allowed between each test. No 
significant differences were found in dyspnea recovery time breathing oxygen (271 s), room air (290 s) or compressed 
air (3 11 s). When the groups were sorted by sequence of testing, there was a highly significant increase in recovery 
time (208 s, 307 s and 358 s for the first, second and third tests; P<O.O05) and a non-statistically significant decrease 
in exercise duration (89 s, 79 s and 76 s). Post-exercise oxygen supplementation had no effect on dyspnea recovery 
time in these COPD patients. Repeated bouts of exercise increased dyspnea recovery time and tended to decrease 
exercise duration. These findings suggest that, despite recovery of symptoms, physiological recovery from prior 
exercise is incomplete. 
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Introduction 
Exercise performance is impaired in patients with chronic 
obstructive pulmonary disease (COPD) by reduced ventila- 
tory capacity (1,2), ventilatory inefficiency (high V,/ V,), 
and physical deconditioning leading to premature lactic 
acidosis (3). Administration of supplemental oxygen 
improves exercise tolerance and reduces breathlessness in 
COPD patients (4); this is achieved by a reduction in 
ventilatory requirement for the same work load (5). Pre- 
exercise administration of oxygen was shown to reduce 
breathlessness for short exercise bouts in these patients (4). 
Oxygen is commonly used by COPD patients to 
relieve dyspnea during recovery from exercise. Despite the 
beneficial effect of oxygen inhalation on exercise perform- 
ance of COPD patients, its effect on exercise recovery is 
unclear. In one study (6), 19 COPD patients inhaled 
oxygen, room air or compressed air during recovery from 
maximal exercise using a 3 1 cm step. While 11 felt relief of 
breathlessness as shown by visual analog scales (VA%), 
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respiratory rate and heart rate were not affected by the gas 
inhaled. Furthermore, these results were not reproducible in 
later tests on the same patients. 
The present study was designed to ascertain the effect of 
oxygen breathing and repeated bouts of maximal treadmill 
exercise on dyspnea recovery time in COPD patients. We 
chose treadmill walking as an exercise that is closely related 
to everyday exercise activities. Our hypothesis was that 
repeated bouts of exercise would tend to prolong recovery 
time breathing room air and that breathing supplemental 
oxygen would shorten recovery time. 
Materials and Methods 
STUDY DESIGN 
This was a randomized, cross-over, single-blind trial to 
compare compressed oxygen, compressed air and room air 
on recovery from exercise-induced dyspnea. The subjects 
were unaware of the type of compressed gas being admin- 
istered. In order to minimise unconscious bias, the 
supervising technician used standard statements of encour- 
agement for each test. Random numbers were generated 
from a random number table to establish the sequence of 
gas administered during recovery from each of the three 
tests. 
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SUBJECTS 
Eighteen COPD patients with severe airflow obstruction 
(FEV, ~40% predicted) were recruited (14 male, four 
female). They were clinically stable without evidence of a 
significant exacerbation of their airflow obstruction within 
3 months prior to participation in the study. Exclusion 
criteria were the presence of symptomatic ischemic heart 
disease, asthma with reversibility of FEV, > 15% after 
inhalation of 4OOpg of salbutamol or exercise tolerance 
limited by other disabling disease. The study received 
Human Subject Protection Committee approval and 
participants gave written informed consent. 
METHODS 
All patients had lung volumes and forced expiratory flows 
measured by spirometry. Functional residual capacity 
(FRC) was measured using the helium dilution technique. 
The transfer factor for carbon monoxide (mC0) was 
determined by the single-breath technique. Arterial blood 
gases were measured at rest while room air was being 
breathed. The subjects were familiarized with walking on a 
treadmill and with the use of a 100 mm VAS. 
The exercise tests were performed on a treadmill 
ergometer with 0% grade. The treadmill speed was adjusted 
immediately before the first test to suit each individual 
subject, based on comfort and preference. The same tread- 
mill grade and speed were then used for all subsequent tests. 
On the day of testing, three exercise bouts were performed 
with the subject breathing room air. During the recovery 
periods the subject breathed room air, compressed air or 
compressed oxygen as randomly assigned. The chosen 
recovery time of 20 min allowed for complete recovery of 
symptoms after each study. Compressed air and oxygen 
were delivered through a low-flow face mask (M/C mask). 
The gas flow was fixed at 10 1 min - ’ for both compressed 
air and oxygen. This type of mask delivers a fractional 
inspired oxygen concentration (FIO,) of approximately 
40%. The experimental conditions were intended to reflect 
the clinical circumstances under which patients take supple- 
mental oxygen, accepting that an absolutely constant JIO, 
could not be guaranteed during oxygen administration. The 
VAS for breathlessness was completed immediately when 
exercise stopped and at 30 s intervals until the score was less 
than, or within 5 mm of, the baseline. A 20 min rest period 
after complete subjective recovery followed each exercise 
bout. 
STATISTICAL ANALYSIS 
Anthropometric, pulmonary function and arterial blood 
gas data were expressed as mean & SD. Data were entered 
into a microcomputer data base and analysed with a 
commercial statistical package. The results for the different 
testing conditions were compared using two-way analysis of 
variance for repeated measures. Differences between means 
were assessed using Student’s t test for paired data with 
Bonferroni corrections whenever appropriate. Values of 
PcO.05 were considered significant. 
TABLE 1. Pulmonary function and arterial blood gas analy- 
sis in the 18 subjects 
Age (years) 63.3 =t 5.8 
FEV, (1) 0.87 f 0.44 
FEV, (%) 27* 13 
FVC (1) 1.87 f 0.63 
TLC (1) 5.49 f 1.38 
RV/TLC (%) 55.5 f 7.7 
TLC0 (ml min ~ r mmHg - ‘) 10.3 f 5.8 
PaO, (kPa) 6.8 It 1.5 
PaCO, (kPa) 6.1 + 1.1 
Values are mean & standard deviation. 
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FIG. 1. Exercise @) and recovery ) times sorted by gas 
breathed: room air (RA), compressed air (CA) or oxygen 
(02). 
Results 
Eighteen patients completed the study. Table 1 shows age, 
baseline pulmonary function data and arterial blood gases 
for the group. They had moderately severe airflow obstruc- 
tion, hyperinflation, impaired gas transfer, hypoxemia and 
hypercapnia. 
When the exercise tests were grouped according to the 
gas breathed during recovery, no significant difference was 
observed in exercise duration or dyspnea recovery time 
(Fig. 1). For breathing room air, exercise duration was 
81& 8 s and dyspnea recovery time was 290 * 37 s. For 
breathing oxygen, exercise duration was 83 & 7 s and 
dyspnea recovery time was 271 & 33 s. For breathing com- 
pressed air, exercise duration was 81 i 8 s and recovery 
time was 3 11 * 39 s. 
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FIG. 2. Exercise (N) and recovery ) times sorted by test 
sequence. Statistical significance: *P<O.OS; **PCO.Ol; 
***P<O.OOl (paired t test). 
When the studies were analysed according to the 
sequence in which they were performed, a highly significant 
prolongation of dyspnea recovery time was observed with 
each consecutive test while the actual duration of exercise 
became shorter (Fig. 2). On the first test, the exercise 
duration was 89 * 8 s and the dyspnea recovery time was 
208 * 23 s. On the second test, exercise duration was 
79 & 7 s and dyspnea recovery time was 307 * 31 s 
(P<O.Ol). On the third test, exercise duration was 76 + 7 s 
and dyspnea recovery time was 358 5443 s (P<O.OOl). 
Values are means * SEM and statistical comparisons are 
with the first test. 
Discussion 
Unexpectedly, we found no effect of post-exercise oxygen 
breathing on dyspnea recovery time in our COPD patients. 
Previous exercising significantly prolonged recovery time 
and tended to shorten exercise time. 
In the analysis comparing different gases inhaled during 
recovery, the duration of exercise was consistent between 
subgroups. Naturally, we would not expect oxygen 
administration during the recovery period to influence the 
duration of the preceding exercise bout; rather this shows 
that a bias due to exercise repetition was unlikely to be 
affecting our results. We believe the number of subjects 
participating in this study was sufficient to overcome a type 
II statistical error. However, since the influence of the 
sequence of tests is so great, this might have confounded a 
much smaller effect from the gas inhaled during recovery. 
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Nevertheless, if such an effect existed, our study suggests 
that it is too small to have clinical relevance. 
Our results contrast with those of a previous study which 
reported shorter dyspnea recovery time in COPD subjects 
with oxygen supplementation (6). In this previous study, 
however, the investigators were unable to demonstrate a 
consistent response when the step-exercise protocol was 
repeated in some of their subjects. In our study, repetition 
of treadmill walking exercise led to prolongation of 
recovery time. Exercise time was reduced by 14.6%, when 
comparing the first and the last exercise bout; however, this 
was not statistically significant using repeated-measures 
analysis of variance. The increase in recovery time was 
much greater: 47.5% following the second exercise bout 
(P<O.Ol) and 72% following the third (P<O.OOl). Evans 
et al. (6) also reported an increased recovery time but 
no decrease in exercise duration for their step-exercise 
protocol. 
Repetition of heavy exercise in healthy subjects does not 
affect maximum oxygen uptake but reduces endurance time 
when the tests are separated by less than 30 min (7). In 
COPD patients I’O, kinetics is slowed, causing a greater 
oxygen debt (8). Post-exercise lactic acid levels are likely 
to be higher, resulting in prolonged elevation of carbon 
dioxide output and I’,. Hence it is likely that the patients 
we studied had not achieved full metabolic recovery before 
starting the next exercise bout. Nevertheless, breathlessness 
scores were observed to have returned to less than or within 
5 mm of baseline during each recovery period. Since it is 
known that the VAS score correlates with V, both during 
exercise and recovery (9), it is likely that V, in our subjects 
was close to baseline before the next exercise bout; however, 
we did not measure VE directly. 
In normal subjects, dyspnea during exercise correlates 
with minute ventilation (V,). Also hypoxemia and hyper- 
capnia have been shown to contribute to the sensation of 
dyspnea and could do so by stimulating an increase in 
ventilation rather than as a direct effect (10,11,12). As with 
normal subjects, COPD patients also show that ventilatory 
parameters during exercise are most closely related to 
dyspnea (13,14). Assuming that an increased elimination of 
carbon dioxide continues during recovery from exercise in 
these patients then carbon dioxide could be the predomi- 
nant stimulus to ventilation and dyspnea during recovery 
(15). This could explain why oxygen supplementation is not 
effective in relieving dyspnea. 
Another important consideration in COPD patients is 
the possibility of muscle fatigue during and following 
exhausting exercise. Respiratory muscles, as well as other 
skeletal muscles, exhibit both high- and low-frequency 
fatigue (16). Both types of fatigue would be expected to last 
longer than the duration of this study protocol and could 
have contributed to the trend towards a shorter endurance 
time with the second and third tests. 
Importantly, from a clinical standpoint, although 
patients feel recovered and prepared to exercise again 
between 20 and 30 min after exhaustive walking exercise, 
the increase in recovery time we have demonstrated implies 
that physiological recovery is not complete. We also con- 
clude that oxygen administration during exercise recovery 
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in COPD patients has no effect on reducing dyspnea 
recovery time and thus should not be recommended as 
intermittent treatment for post-exercise dyspnea in these 
patients unless specifically given to correct hypoxemia. 
These conclusions have clinical relevance for patients 
involved in exercise rehabilitation for COPD. 
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